These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 19237549)
1. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells. Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549 [TBL] [Abstract][Full Text] [Related]
2. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a. Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191 [TBL] [Abstract][Full Text] [Related]
3. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells. Yoo BS; Boverhof DR; Shnaider D; Crawford RB; Zacharewski TR; Kaminski NE Toxicol Sci; 2004 Feb; 77(2):272-9. PubMed ID: 14600275 [TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells. Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995 [TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells. Sulentic CE; Holsapple MP; Kaminski NE Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351 [TBL] [Abstract][Full Text] [Related]
6. A bistable switch underlying B-cell differentiation and its disruption by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin. Bhattacharya S; Conolly RB; Kaminski NE; Thomas RS; Andersen ME; Zhang Q Toxicol Sci; 2010 May; 115(1):51-65. PubMed ID: 20123757 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous in vivo time course and dose response evaluation for TCDD-induced impairment of the LPS-stimulated primary IgM response. North CM; Crawford RB; Lu H; Kaminski NE Toxicol Sci; 2009 Nov; 112(1):123-32. PubMed ID: 19675145 [TBL] [Abstract][Full Text] [Related]
8. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation. North CM; Crawford RB; Lu H; Kaminski NE Toxicol Sci; 2010 Jul; 116(1):99-112. PubMed ID: 20348231 [TBL] [Abstract][Full Text] [Related]
9. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. Sulentic CE; Holsapple MP; Kaminski NE J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109 [TBL] [Abstract][Full Text] [Related]
10. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6. Phadnis-Moghe AS; Crawford RB; Kaminski NE Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051 [TBL] [Abstract][Full Text] [Related]
11. All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin. Zhang Q; Kline DE; Bhattacharya S; Crawford RB; Conolly RB; Thomas RS; Andersen ME; Kaminski NE Toxicol Appl Pharmacol; 2013 Apr; 268(1):17-26. PubMed ID: 23357550 [TBL] [Abstract][Full Text] [Related]
12. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells. Crawford RB; Sulentic CE; Yoo BS; Kaminski NE Toxicol Sci; 2003 Oct; 75(2):333-42. PubMed ID: 12883080 [TBL] [Abstract][Full Text] [Related]
13. 2,3,7,8-tetrachlorodibenzo-p-dioxin induces transcriptional activity of the human polymorphic hs1,2 enhancer of the 3'Igh regulatory region. Fernando TM; Ochs SD; Liu J; Chambers-Turner RC; Sulentic CE J Immunol; 2012 Apr; 188(7):3294-306. PubMed ID: 22357631 [TBL] [Abstract][Full Text] [Related]
14. Stochastic modeling of B lymphocyte terminal differentiation and its suppression by dioxin. Zhang Q; Bhattacharya S; Kline DE; Crawford RB; Conolly RB; Thomas RS; Kaminski NE; Andersen ME BMC Syst Biol; 2010 Apr; 4():40. PubMed ID: 20359356 [TBL] [Abstract][Full Text] [Related]
15. Changes in DNA methylation and gene expression during 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced suppression of the lipopolysaccharide-stimulated IgM response in splenocytes. McClure EA; North CM; Kaminski NE; Goodman JI Toxicol Sci; 2011 Apr; 120(2):339-48. PubMed ID: 21212295 [TBL] [Abstract][Full Text] [Related]
16. An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation. De Abrew KN; Kaminski NE; Thomas RS Toxicol Sci; 2010 Dec; 118(2):454-69. PubMed ID: 20819909 [TBL] [Abstract][Full Text] [Related]
17. Induction of the aryl hydrocarbon receptor-responsive genes and modulation of the immunoglobulin M response by 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary human B cells. Lu H; Crawford RB; Suarez-Martinez JE; Kaplan BL; Kaminski NE Toxicol Sci; 2010 Nov; 118(1):86-97. PubMed ID: 20702590 [TBL] [Abstract][Full Text] [Related]
18. Regulation of Bach2 by the aryl hydrocarbon receptor as a mechanism for suppression of B-cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. De Abrew KN; Phadnis AS; Crawford RB; Kaminski NE; Thomas RS Toxicol Appl Pharmacol; 2011 Apr; 252(2):150-8. PubMed ID: 21296099 [TBL] [Abstract][Full Text] [Related]
19. Interactions at a dioxin responsive element (DRE) and an overlapping kappaB site within the hs4 domain of the 3'alpha immunoglobulin heavy chain enhancer. Sulentic CE; Kang JS; Na YJ; Kaminski NE Toxicology; 2004 Aug; 200(2-3):235-46. PubMed ID: 15212819 [TBL] [Abstract][Full Text] [Related]
20. The AhR and NF-κB/Rel Proteins Mediate the Inhibitory Effect of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on the 3' Immunoglobulin Heavy Chain Regulatory Region. Salisbury RL; Sulentic CE Toxicol Sci; 2015 Dec; 148(2):443-59. PubMed ID: 26377645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]